🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Androgens can cause the growth of prostate cancer cells. Luteini...
Status
Completed
Location
The Jikei University School of Medicine
Start Date
2008-04
Trial ID
NCT00664456
Treatments Being Tested
Fibroids are present in up to 80% of women of reproductive age. Associated ...
Status
Completed
Location
University of Edinburgh/ Royal Infirmary of Edinburgh
Start Date
2008-12
Trial ID
NCT00746031
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled study conducted in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-08-29
Trial ID
NCT03671330
Treatments Being Tested
This open-label research study is studying (Z)-endoxifen as a possible trea...
Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Start Date
2023-02-14
Trial ID
NCT05607004
Treatments Being Tested
Patients with prostate cancer should have the following examination includi...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT01813097
The primary objective of the study is to determine the therapeutic dose of ...
Status
Active Not Recruiting
Location
State Budgetary Healthcare Institution of the Arkhangelsk Region "Arkhangelsk Oncology Dispensary"
Start Date
2024-10-24
Trial ID
NCT07553988
This study will recruit 168 patients in approximately 20 study centres in C...
Status
Withdrawn
Location
Research Site
Start Date
2020-03-31
Trial ID
NCT03658213
Treatments Being Tested
This Investigator-initiated, Treatment of High-Risk Prostate Cancer Guided ...
Status
Recruiting
Location
ZAS Sint-Augustinus
Start Date
2023-12-13
Trial ID
NCT06282588
This was a national, multi-center, open-label, phase IIIb trial to determin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-24
Trial ID
NCT03096847
Treatments Being Tested